BiotechTube

Desloratadine + Zyrtec® (cetirizine)

ApprovedCompleted
0 watching 0 views this week🔥 Hot
80
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Allergies

Conditions

Allergies

Trial Timeline

Aug 1, 2005 → Oct 1, 2005

NCT ID
NCT00780403

About Desloratadine + Zyrtec® (cetirizine)

Desloratadine + Zyrtec® (cetirizine) is a approved stage product being developed by Organon for Allergies. The current trial status is completed. This product is registered under clinical trial identifier NCT00780403. Target conditions include Allergies.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT00779116ApprovedCompleted
NCT00780403ApprovedCompleted

Competing Products

5 competing products in Allergies

See all competitors
ProductCompanyStageHype Score
MK0524MerckPhase 2
52
DupilumabRegeneron PharmaceuticalsPhase 2
51
Cetirizine HCl/Pseudoephedrine HCl 5 mg/120 mg Tablets (Sandoz, USA) + Zyrtec-D 12 Hour 5 mg/120 mg Extended Release Tablets (Pfizer, USA)Sandoz GroupPhase 1
30
Cetirizine HCl/Pseudoephedrine HCl 5 mg/120 mg (Sandoz, USA) + Zyrtec-D 12 Hour 5 mg/120 mg Extended Release Tablets (Pfizer, USA)Sandoz GroupPhase 1
30
Desloratadine + Zyrtec® (cetirizine)OrganonApproved
80

Other Products from Organon

desloratadineApproved
80
tibolone + raloxifenApproved
80
ezetimibe + statinsApproved
80
losartan potassium + Comparator: carvedilol + Comparator: losartan (+) hydrochlorothiazide (HCTZ) + Comparator: carvedilol (+) hydrochlorothiazideApproved
80
Desloratadine 5 mg + fexofenadineApproved
80